Medical treatment of systemic graves’ disease

Jeffrey I. Mechanick

doi:10.3109/9780203908983-18

Medical treatment of systemic graves’ disease

Jeffrey I. Mechanick

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

The management of Graves’ hyperthyroidism has evolved in recent years chiefly due to a better understanding of the underlying molecular immunology and an “evidence-based” approach to clinical controversies. Since patients with Graves’ disease can present with signs and symptoms of orbitopathy, the ophthalmologist must recognize the signs and symptoms of, as well as the treatment options for, the associated thyrotoxicosis. In this chapter, an evidence-based algorithmic approach to the medical management of Graves’ hyperthyroidism is discussed.

Original language	English
Title of host publication	Thyroid Eye Disease
Subtitle of host publication	Diagnosis and Treatment
Publisher	CRC Press
Pages	155-169
Number of pages	15
ISBN (Electronic)	9780824743871
ISBN (Print)	9780824707712
DOIs	https://doi.org/10.3109/9780203908983-18
State	Published - 1 Jan 2002

Access to Document

10.3109/9780203908983-18

Cite this

@inbook{ba54bc9e2bfe4fb2bdb25338a9fa8eb6,

title = "Medical treatment of systemic graves{\textquoteright} disease",

abstract = "The management of Graves{\textquoteright} hyperthyroidism has evolved in recent years chiefly due to a better understanding of the underlying molecular immunology and an “evidence-based” approach to clinical controversies. Since patients with Graves{\textquoteright} disease can present with signs and symptoms of orbitopathy, the ophthalmologist must recognize the signs and symptoms of, as well as the treatment options for, the associated thyrotoxicosis. In this chapter, an evidence-based algorithmic approach to the medical management of Graves{\textquoteright} hyperthyroidism is discussed.",

author = "Mechanick, \{Jeffrey I.\}",

note = "Publisher Copyright: {\textcopyright} 2002 by Taylor \& Francis Group, LLC.",

year = "2002",

month = jan,

day = "1",

doi = "10.3109/9780203908983-18",

language = "English",

isbn = "9780824707712",

pages = "155--169",

booktitle = "Thyroid Eye Disease",

publisher = "CRC Press",

}

TY - CHAP

T1 - Medical treatment of systemic graves’ disease

AU - Mechanick, Jeffrey I.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The management of Graves’ hyperthyroidism has evolved in recent years chiefly due to a better understanding of the underlying molecular immunology and an “evidence-based” approach to clinical controversies. Since patients with Graves’ disease can present with signs and symptoms of orbitopathy, the ophthalmologist must recognize the signs and symptoms of, as well as the treatment options for, the associated thyrotoxicosis. In this chapter, an evidence-based algorithmic approach to the medical management of Graves’ hyperthyroidism is discussed.

AB - The management of Graves’ hyperthyroidism has evolved in recent years chiefly due to a better understanding of the underlying molecular immunology and an “evidence-based” approach to clinical controversies. Since patients with Graves’ disease can present with signs and symptoms of orbitopathy, the ophthalmologist must recognize the signs and symptoms of, as well as the treatment options for, the associated thyrotoxicosis. In this chapter, an evidence-based algorithmic approach to the medical management of Graves’ hyperthyroidism is discussed.

UR - https://www.scopus.com/pages/publications/85056974278

U2 - 10.3109/9780203908983-18

DO - 10.3109/9780203908983-18

M3 - Chapter

AN - SCOPUS:85056974278

SN - 9780824707712

SP - 155

EP - 169

BT - Thyroid Eye Disease

PB - CRC Press

ER -

Medical treatment of systemic graves’ disease

Abstract

Access to Document

Fingerprint

Cite this